Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Regulation of Sodium and Potassium01:26

Regulation of Sodium and Potassium

The regulation of sodium and potassium ion concentrations in the human body is a complex process governed primarily by hormones such as aldosterone, antidiuretic hormone (ADH), and atrial natriuretic peptide (ANP).
Sodium Regulation
Sodium ions make up approximately 90% of extracellular cations, with a normal blood plasma concentration of 136–148 mEq/L. A decrease in blood volume and pressure triggers the release of renin from granular cells in the juxtaglomerular complex (JGC), primarily in...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various tubules...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Echocardiographically occult nonbacterial thrombotic endocarditis with tumor cell-containing valvular vegetations in metastatic breast cancer.

Cardio-oncology (London, England)·2026
Same author

A Screening Method for Determining Left Ventricular Systolic Function Based on Spectral Analysis of a Single-Channel Electrocardiogram Using Machine Learning Algorithms.

Diagnostics (Basel, Switzerland)·2026
Same author

Prognostic Value of Early Rehospitalization in Heart Failure Patients.

Journal of clinical medicine·2025
Same author

Plasma Fatty Acid Profiling and Mathematical Estimation of the Omega-3 Index: Toward Diagnostic Tools in Atherosclerosis and Statin Therapy Monitoring.

Biomedicines·2025
Same author

Author Correction: THBru attenuates diabetic cardiomyopathy by inhibiting RAGE-dependent inflammation.

Acta pharmacologica Sinica·2025
Same author

Venous Excess Ultrasound Score Is Associated with Worsening Renal Function and Reduced Natriuretic Response in Patients with Acute Heart Failure.

Journal of clinical medicine·2024

Related Experiment Video

Updated: May 13, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Hyponatremia: an update on current pharmacotherapy.

Dmitry Shchekochikhin1, Oleksandra Tkachenko, Robert W Schrier

  • 1University of Colorado, School of Medicine, 12700 East 19th Ave C281, Aurora, CO 80045, USA.

Expert Opinion on Pharmacotherapy
|March 19, 2013
PubMed
Summary

Vasopressin receptor antagonists effectively treat moderate hyponatremia by increasing water excretion. Further research is needed to evaluate their impact on severe hyponatremia outcomes.

More Related Videos

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
11:51

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters

Published on: February 3, 2018

Related Experiment Videos

Last Updated: May 13, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters
11:51

Application of Electrophysiology Measurement to Study the Activity of Electro-Neutral Transporters

Published on: February 3, 2018

Area of Science:

  • Nephrology
  • Endocrinology
  • Internal Medicine

Background:

  • Hyponatremia, a common electrolyte disorder, presents risks including cerebral edema, hypoxia, gait instability, and cognitive dysfunction.
  • It is primarily caused by nonosmotic arginine vasopressin secretion, leading to electrolyte-free water retention.
  • Management strategies aim to increase solute-free water excretion, often by blocking vasopressin receptors.

Purpose of the Study:

  • To review the efficacy and safety of vasopressin receptor antagonists (vaptans) in managing hyponatremia.
  • To summarize findings from recent clinical trials on vaptan therapy.
  • To discuss the potential of vaptans in various hyponatremic conditions.

Main Methods:

  • Review of recent clinical trials assessing vasopressin receptor antagonists for hyponatremia treatment.
  • Analysis of vaptan efficacy in reversing hyponatremia, including hypervolemic states.
  • Examination of the impact of vaptans on solute-free water excretion.

Main Results:

  • Vasopressin receptor antagonists have demonstrated efficacy in reversing hyponatremia.
  • Vaptan treatment for hypervolemic hyponatremia increases solute-free excretion without activating neurohumoral systems.
  • Agents like vaptans and urea can reverse moderate hyponatremia.

Conclusions:

  • Vasopressin receptor antagonists are effective in managing moderate hyponatremia.
  • Current clinical trials have not assessed vaptans for severe hyponatremia.
  • Future research should investigate the impact of vaptans on morbidity and mortality in severe hyponatremic states.